Naxcel
| Species | Swine. |
|---|---|
| Composition |
Naxcel 100 mg/ml Active substance: Ceftiofur (in crystallized form without acid) 100 mg Excipients: Medium-chain triglycerides: 7913 mg Cottonseed oil: 856 mg |
| Indications |
Treatment of bacterial respiratory conditions associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus parasuis, and Streptococcus suis. Treatment of septicemia, polyarthritis, and polyserositis associated with Streptococcus suis infection. |
| Dosage and method of administration |
The dose of 5 mg ceftiofur/kg body weight, equivalent to 1 ml of Naxcel per 20 kg body weight, is administered as a single injection into the neck region by intramuscular injection. The bottle should be shaken vigorously for 30 seconds or until any visible sediment disappears. To ensure accurate dosing, the body weight must be determined precisely to avoid underdosing. It is recommended to limit the injected volume to a maximum of 4 ml. Intramuscular administration. |
| Contraindications | It should not be used in cases of hypersensitivity to ceftiofur or other beta-lactam antibiotics, or to any of the excipients. |
| Waiting period | Meat and organs: 71 days. |
| Release form |
Cardboard box with a Type I glass bottle of 50 ml or 100 ml, with a chlorobutyl-isoprene rubber stopper and an aluminum cap. Not all packaging sizes may be available for sale. |
| Storage conditions |
Do not store at temperatures higher than +25°C. Protect from light. |
| Shelf life |
The shelf life of the veterinary medicinal product, as packaged for sale, is 2 years. The shelf life after the first opening of the primary packaging is 28 days. |